Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06921902 · ClinicalTrials.gov registry record
Glycemic Metrics and Patterns in People With and Without Prediabetes
A clinical trial of PreDiabetes, sponsored by Abbott Diabetes Care.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT06921902: Recruiting study of PreDiabetes, sponsored by Abbott Diabetes Care.
NCT06921902 is a study of PreDiabetes that is actively recruiting participants, run by Abbott Diabetes Care. The registered enrollment target is 2,000 participants, above the 688-participant average among 149 other PreDiabetes trials with a reported enrollment target (191% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06921902, a study of PreDiabetes, is actively recruiting participants, sponsored by Abbott Diabetes Care.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Primary Outcome
This is a data collection study.
Conditions Studied
Interventions
- DEVICE FreeStyle Libre 3
Study Locations (1)
Oregon
- Diabetes and Obesity Care - Bend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2026-07 |
What NCT06921902 shows while recruiting
NCT06921902 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 688-participant average among 149 other PreDiabetes trials with a reported enrollment target (191% higher).
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre 3 is the first listed.
NCT06921902 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06921902 about?
NCT06921902 is a clinical study titled "Glycemic Metrics and Patterns in People With and Without Prediabetes". The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
What is the current status of trial NCT06921902?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2025-02-28. Estimated completion is 2026-07.
What conditions does trial NCT06921902 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT06921902?
The interventions under investigation include: FreeStyle Libre 3 (DEVICE).
Who is sponsoring clinical trial NCT06921902?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06921902 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06921902's enrollment target sits among peer trials
2,000 8th of 149 higher than 142 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Glucose Variability and Cognition in Prediabetes
RECRUITING
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI